Serge Boyer

Serge Boyer has a strong background in process chemistry and CMC, with extensive experience in the pharmaceutical industry. Serge is currently serving as the Senior Director of Process Chemistry at AN2 Therapeutics since February 2023. Before that, they held the position of Senior Director of CMC at Qpex Biopharma from October 2018 to October 2022. In this role, they developed processes for the large-scale synthesis of xeruborbactam and its prodrug, assisted with the execution and planning of various studies, and played a key role in manufacturing clinical drug supply. Prior to Qpex Biopharma, Serge worked at Mpex/Rempex/The Medicines Company as a Director of Process Chemistry from March 2010 to October 2018. Here, they developed processes for the large-scale synthesis of lead drug candidates and co-developed the process for the multi-ton synthesis of vaborbactam. Serge also played an important role in identifying potential CDMOs, transferring processes, and assisting in the manufacturing of clinical drug supply. Before that, Serge worked at Mpex Pharmaceuticals as a Medicinal Chemistry Consultant for a brief period in 2010. Serge co-invented a new formulation of Minocin® (minocycline) for injection during this time. Serge also has experience working as a Medicinal Chemistry Consultant and Director of Medicinal Chemistry at Metabasis Therapeutics. In these roles, they managed research teams, established drug discovery programs, and was responsible for the synthesis, characterization, and scale-up of new compounds. Some of their notable achievements include the discovery and development of the clinical candidate MB07811 for the treatment of hypercholesterolemia and hyperlipidemia, as well as the discovery and development of the clinical candidate MB07133 for hepatocellular carcinoma. Throughout their career, Serge Boyer has showcased strong expertise in process chemistry, CMC, and medicinal chemistry.

Serge Boyer's education history is as follows: they obtained a Ph.D. in Synthetic Organic Chemistry from Yale University, but the exact start and end years are unknown. Prior to that, they completed their studies at Ecole supérieure de Chimie organique et minérale, where they earned an Ingenieur degree in Chemistry. Again, the specific years of their education at this institution are not provided.